General review
Micromethod for the determination of 3-β-HSD activity in cultured cells

https://doi.org/10.1016/0022-4731(89)90054-XGet rights and content

Abstract

A modified radioassay for the determination of the 3β-hydroxy-Δ5-steroid dehydrogenase (3-β-HSD) is described. The assay is based on the conversion of [3H]pregnenolone to [3H]progesterone followed by a digitonin precipitation step. The method was applied to neurons, glial cells, C6 glioma cells and adrenal tumor cells in culture. Adrenal tumor cells and C6 glioma cells showed higher enzyme activity than primary cultures of astrocytes and neurons. Dependence of enzyme activity on pH, protein concentration and reaction time was demonstrated for C6 cells. A pH optimum was shown between 7.5 and 8.1, and the reaction was linear up to 2 h. β-oestradiol inhibited 3-β-HSD activity completely. The assay presented is fast, highly reproducible, and offers the possibility of studying 3-β-HSD activity in differentiating cells in culture without preparation of microsomes or extraction of reaction products.

Cited by (26)

  • Molecular reproductive characteristics of the reef coral Pocillopora damicornis

    2015, Comparative Biochemistry and Physiology -Part A : Molecular and Integrative Physiology
    Citation Excerpt :

    The 3βHSD enzyme is responsible for the catalysis of progestagens and androgens, including the conversion of pregnenolone to progesterone. The activity of 3βHSD was determined by measuring the conversion of pregnenolone to progesterone as previously described (Bauer and Bauer, 1989; Raunig et al., 2011). ELISA and values were converted to ng/min/mg of protein using a standard curve of progesterone (manufacturer supplied).

  • Assisted reproduction technologies alter steroid delivery to the mouse fetus during pregnancy

    2011, Journal of Steroid Biochemistry and Molecular Biology
    Citation Excerpt :

    Percent areas were calculated from whole compound pictures and percentages presented are rounded to the nearest whole number. Assays for 3-β-hydroxysteroid dehydrogenase (3β-HSD) and cytochrome P450 17α-hydroxylase (CYP17) were performed using maternal livers (n = 3 each for IVF, ICSI and normal reproduction), ovaries (IVF, n = 2, ICSI, n = 4, normal reproduction n = 1), and fetal livers (IVF, n = 35, ICSI, n = 25, normal reproduction n = 26) using published protocols [13–15]. The assay for 3βHSD proceeded by addition of 10 μL of protein (0.05 mg/mL liver or 0.01 mg/mL ovaries), 79 μL of assay buffer (0.1 M Tris–HCl buffer with 50 mM MgCl2, pH 7.4) and 1 μL of pregnenolone (500 μM stock) to a 1.7 mL microtube.

  • Steroidogenic enzymes in the brain: Morphological aspects

    2010, Progress in Brain Research
    Citation Excerpt :

    The first data on the presence of 3β-HSD in the brain have been provided by Weidenfeld et al., (1980), who showed that homogenates of rat amygdala and septum could convert pregnenolone into progesterone. Subsequent studies have confirmed the existence of bioactive 3β-HSD in brain tissues and primary cultures of oligodendrocytes and neurons (Bauer and Bauer, 1989; Robel et al., 1986; Ukena et al., 1999). Type 1 3β-HSD mRNA has been detected in several regions of the rat brain including the olfactory bulb, the olfactory tubercle, the caudate putamen, the nucleus accumbens, the cerebral cortex, the thalamus, the hypothalamus, the hippocampus, the septum, the medial habenular nucleus, the nucleus vestibularis lateralis, the nucleus vestibularis medialis, the nucleus vestibularis spinalis and the cerebellum (Dupont et al., 1994; Furukawa et al., 1998; Guennoun et al., 1995; Kohchi et al., 1998; Meffre et al., 2007; Sanne and Krueger, 1995; Ukena et al., 1999).

  • Neurosteroid biosynthesis: Enzymatic pathways and neuroendocrine regulation by neurotransmitters and neuropeptides

    2009, Frontiers in Neuroendocrinology
    Citation Excerpt :

    i) The occurrence of steroidogenic enzymes or their mRNAs has been evidenced, respectively, by immunohistochemistry or in situ hybridization studies, either in neurons or in glial cells, depending on the species and the enzyme considered [486,487,492,493,494,495,524,623,625,626,720,745,782,792]. ( ii) The corresponding enzymatic activities were demonstrated through the ability of brain tissue to convert tritiated precursors such as cholesterol or 5P into radioactive metabolites including 7α-hydroxypregnenolone (7αΟΗ-Δ5P), 17-hydroxypregnenolone (17OH-5P), progesterone (P), 17-hydroxyprogesterone (17OH-P), DHEA, 7α-hydroxydehydroepiandrosterone (7αOH-DHEA), dihydroprogesterone (DHP), tetrahydroprogesterone (THP, allopregnanolone), Δ5PS and DHEAS [54,61,141,177,304,325,454–456,486,492–495,775,779–781,785,792,793]. Concurrently, it became clear that neurosteroids exert a large array of biological activities in the brain [65,382,431,568,739] either through a conventional genomic action or through interaction with membrane receptors.

  • Biosynthesis of Neurosteroids and regulation of their synthesis

    2001, International Review of Neurobiology
View all citing articles on Scopus
View full text